Abstract:OBJECTIVE To investigate whether quinolones may influence theophylline pharmacokinetic parameters.METHODS In self-control desing,the plasma concentrations of theophylline were determined after intravenous dose 10mg·kg~(-1) of theophylline alone,followed by oral administration of quinolones,once daily for 6 days,and determination of the plasma concentrations of theophylline after intravenous dose 10mg·kg~(-1) of theophylline again at the 6~(th) day.The pharmacokinetic parameters of theophylline were estimated. RESULTS The pharmacokinetics of theophylline used alone and coadministered with fleroxacin was fit to one compartment model.The pharmacokinetics parameters of theophylline used alone and coadministered with fleroxacin is as follows:K:0.154±0.035 h~(-1),0.151±0.044 h~(-1);T_(1/2):4.70±1.12 h,4.90±1.38 h;V:0.562±0.180 L·kg~(-1),0.556±0.166 L·kg~(-1);AUC_(0～10):93.70±32.87 mg·h·L~(-1),100.20±43.11 mg·h·L~(-1);AUC_(0～∞):147.87±68.08 mg·h·L~(-1),157.16±80.69 mg·h·L~(-1);CL:(0.090)±0.046 L· kg~(-1)·h~(-1),0.091±0.052 L·kg~(-1)·h~(1);Cmax:19.91±5.25 mg·L~(-1),20.12±5.24 mg·L~(-1).The study suggests that fleroxacin had minor influence on pharmacokinetics of theophylline in rabbits.The two drugs can be administered concurrently.The pharmacokinetics of theophylline used alone and coadministered with rufloxacin was fit to one compartment model.The pharmacokinetics parameters of theophylline used alone and coadministered with rufloxacin is as follows: K: 0.147±0.017 h~(-1),0.148±(0.018) h~(-1);T_(1/2):4.76±0.54 h,4.74±0.56 h;V:0.581±0.089 L·kg~(-1),0.555±0.075 L·kg~(-1);AUC_(0～10):91.42±11.14 mg·h·L~(-1),94.97±10.20mg·h·L~(-1);AUC_(0～∞):119.48±14.96 mg·h·L~(-1),124.05±14.76 mg·h·L~(-1);CL :0.085±0.011 L·kg~(-1)·h~(-1),0.082±0.010L·kg~(-1)·h~(-1);Cmax:18.48±2.53 mg·L~(-1),19.16±2.34mg·L~(-1).The study suggests that rufloxacin had minor influence on pharmacokinetics of theophylline in rabbits.The pharmacokinetics of theophylline used alone and coadministered with pefloxacin was fit to one compartment model.The pharmacokinetic parameters of theophylline used alone and coadministered with pefloxacin is as follows : K: 0.150±0.038 h~(-1),0.110±0.018 h~(-1),P<0.01;T_(1/2):4.95±1.67 h,6.69±2.01 h,P<0.01;V:(0.584)±0.149 L·kg~(-1),0.511±0.126 L· kg~(-1),P<0.05;AΜC_(0～10):97.71±40.09 mg·h·L~(-1),126.11±42.72 mg·h·L~(-1),P<0.01;AΜC_(0～∞):136.05±83.40 mg·h·L~(-1),202.10±99.81 mg·h·L~(-1),P<0.01;CL:0.091±0.038 L·kg~(-1)·h~(-1),(0.056)±0.018 L·kg~(-1)·h~(-1),P<0.01;Cmax:18.94±4.89 mg·L~(-1),21.82±5.40 mg·L~(-1),P<0.05.There were statistical significance between pharmacokinetic parameters of theophylline used alone and coadministered with pefloxacin.The pharmacokinetics of theophylline used alone and coadministered with gatifloxacin was fit to one compartment model.The pharmacokinetic parameters of theophylline used alone and coadministered with gatifloxacin is as follows: K:0.147±0.035 h~(-1),0.127±0.026 h~(-1);T_(1/2):4.89±(0.98) h,5.62±1.09h;V:0.541±0.162 L· kg~(-1),0.538±0.154 L· kg~(-1);AΜC_(0～10):97.81±29.87 mg·h·L~(-1),107.27±(39.54) mg·h·L~(-1);AΜC_(0～∞):153.32±65.64 mg·h·L~(-1),174.01±71.03 mg·h·L~(-1);CL :0.081±0.034 mg·h·L~(-1),(0.074)±(0.033) L·kg~(-1)·h~(-1);Cmax:20.51±5.12 mg·L~(-1),20.60±5.05 mg·L~(-1).There were no statistical significance between pharmacokinetic parameters of theophylline used alone and coadministered with gatifloxacin except T_(1/2).CONCLUSION Fleroxacin and rufloxacin had minor influence on theophylline plasma and pharmacokinetic parameters of theophylline.Pefloxacin had marked influence on theophylline plasma and pharmacokinetic parameters of theophylline.gatifloxacin had minor influence on theophylline plasma and pharmacokinetic parameters of theophylline except T_(1/2).

Effects of quinolones on pharmacokinetics of theophylline

Effect of Moxifloxacin on Pharmacokinetics of Theophylline in Rabbits

Modulation of Pharmacokinetics of Theophylline by Antofloxacin, a Novel 8-Amino-fluoroquinolone, in Humans.

Influence of Pazufloxacin Mesilate on Pharmacokinetics of Aminophylline in Rabbits

The Influence of a Newly Developed Quinolone: Antoflox-acin, on CYP Activity in Rats

Metabolism of theophylline and its inhibition by fluoroquinolones in rat hepatic microsomes.

Study on Pharmacokinetic Interaction of Doxofylline and Moxifloxacin in Rats

The Clinical Pharmacokinetics of Levofloxacin

Pharmacokinetics of Antofloxacin in Rats Co-Administered with Non-Steroidal Anti-Inflammatory Drugs

Effect of Diclofenac on the Pharmacokinetics of Moxifloxacin in Rats.

A physiologically based pharmacokinetic model characterizing mechanism-based inhibition of CYP1A2 for predicting theophylline/antofloxacin interaction in both rats and humans.

Effects Of Rifampin And Ketoconazole On Pharmacokinetics Of Morinidazole In Healthy Chinese Subjects

Alcohol Affect the Pharmacokinetics of Doxofylline and its Metabolite Theophylline in Rats

Drug-Drug Interactions Between Moxifloxacin and Rifampicin Based on Pharmacokinetics in Vivo in Rats

Effects of levofloxacin on the plasma concentration of baicalin in rats

Pharmacokinetic Study of Single and Multiple Oral Dose Administration of Antofloxacin Hydrochloride in Healthy Male Volunteers.

A randomized single-dose safety, pharmacokinetics, food effect and 1 effect on thorough QT/QTc of Chinfloxacin in healthy Chinese 2 Volunteers

Determination of the Inhibitory Potential of 6 Fluoroquinolones on CYP1A2 and CYP2C9 in Human Liver Microsomes

[Study of Pharmacokinetics/pharmacodynamics of Levofloxacin].

Pharmacokinetics of antofloxacin hydrochloride, a new fluoroquinolone antibiotic, after single oral dose administration in Chinese healthy male volunteers.

Comparative effect of ciprofloxacin and moxifloxacin on the modulation of bile acid profiles and gut microbiota in rats